Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pharmaceutical Products and CMO market report explains the definition, types, applications, major countries, and major players of the Pharmaceutical Products and CMO market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Fareva Holding
Recipharm
Famar
Piramal Healthcare
Catalent
AbbVie
Mylan (DPT Laboratories)
Jubilant
Aenova
Boehringer Ingelheim
Sopharma
Dishman
NextPharma Technologies
Lonza
Vetter
Nipro Corp
DPx
Aesica
By Type:
Active Pharmaceutical Ingredient (API)
Finished Dosage Form (FDF)
Pharmaceutical Packaging
By End-User:
Specialty/Midsize
Generics
Big Pharma
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pharmaceutical Products and CMO Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pharmaceutical Products and CMO Outlook to 2028- Original Forecasts
-
2.2 Pharmaceutical Products and CMO Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pharmaceutical Products and CMO Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pharmaceutical Products and CMO Market- Recent Developments
-
6.1 Pharmaceutical Products and CMO Market News and Developments
-
6.2 Pharmaceutical Products and CMO Market Deals Landscape
7 Pharmaceutical Products and CMO Raw Materials and Cost Structure Analysis
-
7.1 Pharmaceutical Products and CMO Key Raw Materials
-
7.2 Pharmaceutical Products and CMO Price Trend of Key Raw Materials
-
7.3 Pharmaceutical Products and CMO Key Suppliers of Raw Materials
-
7.4 Pharmaceutical Products and CMO Market Concentration Rate of Raw Materials
-
7.5 Pharmaceutical Products and CMO Cost Structure Analysis
-
7.5.1 Pharmaceutical Products and CMO Raw Materials Analysis
-
7.5.2 Pharmaceutical Products and CMO Labor Cost Analysis
-
7.5.3 Pharmaceutical Products and CMO Manufacturing Expenses Analysis
8 Global Pharmaceutical Products and CMO Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pharmaceutical Products and CMO Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pharmaceutical Products and CMO Export by Region (Top 10 Countries) (2017-2028)
9 Global Pharmaceutical Products and CMO Market Outlook by Types and Applications to 2022
-
9.1 Global Pharmaceutical Products and CMO Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Finished Dosage Form (FDF) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pharmaceutical Packaging Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharmaceutical Products and CMO Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Specialty/Midsize Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Generics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Big Pharma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pharmaceutical Products and CMO Market Analysis and Outlook till 2022
-
10.1 Global Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.2.2 Canada Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.2.3 Mexico Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.2 UK Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.3 Spain Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.4 Belgium Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.5 France Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.6 Italy Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.7 Denmark Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.8 Finland Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.9 Norway Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.10 Sweden Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.11 Poland Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.12 Russia Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.3.13 Turkey Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.2 Japan Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.3 India Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.4 South Korea Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.5 Pakistan Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.6 Bangladesh Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.7 Indonesia Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.8 Thailand Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.9 Singapore Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.10 Malaysia Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.11 Philippines Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.4.12 Vietnam Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.2 Colombia Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.3 Chile Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.4 Argentina Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.5 Venezuela Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.6 Peru Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.7 Puerto Rico Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.5.8 Ecuador Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.6.2 Kuwait Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.6.3 Oman Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.6.4 Qatar Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.7.2 South Africa Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.7.3 Egypt Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.7.4 Algeria Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pharmaceutical Products and CMO Consumption (2017-2022)
-
10.8.2 New Zealand Pharmaceutical Products and CMO Consumption (2017-2022)
11 Global Pharmaceutical Products and CMO Competitive Analysis
-
11.1 Fareva Holding
-
11.1.1 Fareva Holding Company Details
-
11.1.2 Fareva Holding Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Fareva Holding Pharmaceutical Products and CMO Main Business and Markets Served
-
11.1.4 Fareva Holding Pharmaceutical Products and CMO Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Recipharm
-
11.2.1 Recipharm Company Details
-
11.2.2 Recipharm Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Recipharm Pharmaceutical Products and CMO Main Business and Markets Served
-
11.2.4 Recipharm Pharmaceutical Products and CMO Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Famar
-
11.3.1 Famar Company Details
-
11.3.2 Famar Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Famar Pharmaceutical Products and CMO Main Business and Markets Served
-
11.3.4 Famar Pharmaceutical Products and CMO Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Piramal Healthcare
-
11.4.1 Piramal Healthcare Company Details
-
11.4.2 Piramal Healthcare Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Piramal Healthcare Pharmaceutical Products and CMO Main Business and Markets Served
-
11.4.4 Piramal Healthcare Pharmaceutical Products and CMO Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Catalent
-
11.5.1 Catalent Company Details
-
11.5.2 Catalent Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Catalent Pharmaceutical Products and CMO Main Business and Markets Served
-
11.5.4 Catalent Pharmaceutical Products and CMO Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AbbVie
-
11.6.1 AbbVie Company Details
-
11.6.2 AbbVie Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AbbVie Pharmaceutical Products and CMO Main Business and Markets Served
-
11.6.4 AbbVie Pharmaceutical Products and CMO Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Mylan (DPT Laboratories)
-
11.7.1 Mylan (DPT Laboratories) Company Details
-
11.7.2 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Main Business and Markets Served
-
11.7.4 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Jubilant
-
11.8.1 Jubilant Company Details
-
11.8.2 Jubilant Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Jubilant Pharmaceutical Products and CMO Main Business and Markets Served
-
11.8.4 Jubilant Pharmaceutical Products and CMO Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Aenova
-
11.9.1 Aenova Company Details
-
11.9.2 Aenova Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Aenova Pharmaceutical Products and CMO Main Business and Markets Served
-
11.9.4 Aenova Pharmaceutical Products and CMO Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Boehringer Ingelheim
-
11.10.1 Boehringer Ingelheim Company Details
-
11.10.2 Boehringer Ingelheim Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Boehringer Ingelheim Pharmaceutical Products and CMO Main Business and Markets Served
-
11.10.4 Boehringer Ingelheim Pharmaceutical Products and CMO Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sopharma
-
11.11.1 Sopharma Company Details
-
11.11.2 Sopharma Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sopharma Pharmaceutical Products and CMO Main Business and Markets Served
-
11.11.4 Sopharma Pharmaceutical Products and CMO Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Dishman
-
11.12.1 Dishman Company Details
-
11.12.2 Dishman Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Dishman Pharmaceutical Products and CMO Main Business and Markets Served
-
11.12.4 Dishman Pharmaceutical Products and CMO Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 NextPharma Technologies
-
11.13.1 NextPharma Technologies Company Details
-
11.13.2 NextPharma Technologies Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 NextPharma Technologies Pharmaceutical Products and CMO Main Business and Markets Served
-
11.13.4 NextPharma Technologies Pharmaceutical Products and CMO Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Lonza
-
11.14.1 Lonza Company Details
-
11.14.2 Lonza Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Lonza Pharmaceutical Products and CMO Main Business and Markets Served
-
11.14.4 Lonza Pharmaceutical Products and CMO Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Vetter
-
11.15.1 Vetter Company Details
-
11.15.2 Vetter Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Vetter Pharmaceutical Products and CMO Main Business and Markets Served
-
11.15.4 Vetter Pharmaceutical Products and CMO Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Nipro Corp
-
11.16.1 Nipro Corp Company Details
-
11.16.2 Nipro Corp Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Nipro Corp Pharmaceutical Products and CMO Main Business and Markets Served
-
11.16.4 Nipro Corp Pharmaceutical Products and CMO Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 DPx
-
11.17.1 DPx Company Details
-
11.17.2 DPx Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 DPx Pharmaceutical Products and CMO Main Business and Markets Served
-
11.17.4 DPx Pharmaceutical Products and CMO Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Aesica
-
11.18.1 Aesica Company Details
-
11.18.2 Aesica Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Aesica Pharmaceutical Products and CMO Main Business and Markets Served
-
11.18.4 Aesica Pharmaceutical Products and CMO Product Portfolio
-
11.18.5 Recent Research and Development Strategies
12 Global Pharmaceutical Products and CMO Market Outlook by Types and Applications to 2028
-
12.1 Global Pharmaceutical Products and CMO Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Finished Dosage Form (FDF) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Pharmaceutical Packaging Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pharmaceutical Products and CMO Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Specialty/Midsize Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Generics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Big Pharma Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pharmaceutical Products and CMO Market Analysis and Outlook to 2028
-
13.1 Global Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.2.2 Canada Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.2 UK Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.3 Spain Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.5 France Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.6 Italy Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.8 Finland Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.9 Norway Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.11 Poland Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.12 Russia Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.2 Japan Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.3 India Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.3 Chile Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.6 Peru Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.6.3 Oman Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pharmaceutical Products and CMO Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pharmaceutical Products and CMO
-
Figure of Pharmaceutical Products and CMO Picture
-
Table Global Pharmaceutical Products and CMO Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pharmaceutical Products and CMO Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)
-
Figure Global Finished Dosage Form (FDF) Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Packaging Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty/Midsize Consumption and Growth Rate (2017-2022)
-
Figure Global Generics Consumption and Growth Rate (2017-2022)
-
Figure Global Big Pharma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Table North America Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure United States Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Canada Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table Europe Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure Germany Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure UK Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Spain Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure France Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Italy Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Finland Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Norway Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Poland Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Russia Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table APAC Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure China Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure India Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table South America Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure Brazil Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Chile Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Peru Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table GCC Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure Bahrain Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Oman Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table Africa Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure Nigeria Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table Oceania Pharmaceutical Products and CMO Consumption by Country (2017-2022)
-
Figure Australia Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)
-
Table Fareva Holding Company Details
-
Table Fareva Holding Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fareva Holding Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Fareva Holding Pharmaceutical Products and CMO Product Portfolio
-
Table Recipharm Company Details
-
Table Recipharm Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Recipharm Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Recipharm Pharmaceutical Products and CMO Product Portfolio
-
Table Famar Company Details
-
Table Famar Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Famar Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Famar Pharmaceutical Products and CMO Product Portfolio
-
Table Piramal Healthcare Company Details
-
Table Piramal Healthcare Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Piramal Healthcare Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Piramal Healthcare Pharmaceutical Products and CMO Product Portfolio
-
Table Catalent Company Details
-
Table Catalent Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalent Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Catalent Pharmaceutical Products and CMO Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Pharmaceutical Products and CMO Main Business and Markets Served
-
Table AbbVie Pharmaceutical Products and CMO Product Portfolio
-
Table Mylan (DPT Laboratories) Company Details
-
Table Mylan (DPT Laboratories) Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan (DPT Laboratories) Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Portfolio
-
Table Jubilant Company Details
-
Table Jubilant Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Jubilant Pharmaceutical Products and CMO Product Portfolio
-
Table Aenova Company Details
-
Table Aenova Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aenova Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Aenova Pharmaceutical Products and CMO Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Boehringer Ingelheim Pharmaceutical Products and CMO Product Portfolio
-
Table Sopharma Company Details
-
Table Sopharma Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sopharma Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Sopharma Pharmaceutical Products and CMO Product Portfolio
-
Table Dishman Company Details
-
Table Dishman Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dishman Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Dishman Pharmaceutical Products and CMO Product Portfolio
-
Table NextPharma Technologies Company Details
-
Table NextPharma Technologies Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table NextPharma Technologies Pharmaceutical Products and CMO Main Business and Markets Served
-
Table NextPharma Technologies Pharmaceutical Products and CMO Product Portfolio
-
Table Lonza Company Details
-
Table Lonza Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Lonza Pharmaceutical Products and CMO Product Portfolio
-
Table Vetter Company Details
-
Table Vetter Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vetter Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Vetter Pharmaceutical Products and CMO Product Portfolio
-
Table Nipro Corp Company Details
-
Table Nipro Corp Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nipro Corp Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Nipro Corp Pharmaceutical Products and CMO Product Portfolio
-
Table DPx Company Details
-
Table DPx Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table DPx Pharmaceutical Products and CMO Main Business and Markets Served
-
Table DPx Pharmaceutical Products and CMO Product Portfolio
-
Table Aesica Company Details
-
Table Aesica Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aesica Pharmaceutical Products and CMO Main Business and Markets Served
-
Table Aesica Pharmaceutical Products and CMO Product Portfolio
-
Figure Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Finished Dosage Form (FDF) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Packaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty/Midsize Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Big Pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Table North America Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure United States Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure Germany Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure China Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)
-
Figure Australia Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)
-
